Pharmacogenomic Approach to Identify Drug Sensitivity in Small-Cell Lung Cancer

There are currently no molecular targeted approaches to treat small-cell lung cancer (SCLC) similar to those used successfully against non-small-cell lung cancer. This failure is attributable to our inability to identify clinically-relevant subtypes of this disease. Thus, a more systematic approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Wildey, Gary, Chen, Yanwen, Lent, Ian, Stetson, Lindsay, Pink, John, Barnholtz-Sloan, Jill S., Dowlati, Afshin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157793/
https://www.ncbi.nlm.nih.gov/pubmed/25198282
http://dx.doi.org/10.1371/journal.pone.0106784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157793/
https://www.ncbi.nlm.nih.gov/pubmed/25198282
http://dx.doi.org/10.1371/journal.pone.0106784

Ejemplares similares